Evidence map›Paper›PMID 36860967›Full record

ArticleTherapeutic advances in musculoskeletal disease2023

Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage.

Alberto Migliore, Liudmila Alekseeva, Sachin R Avasthi, Raveendhara R Bannuru, Xavier Chevalier, Thierry Conrozier, Sergio Crimaldi, Gustavo C de Campos, Demirhan Diracoglu, Gianfranco Gigliucci and 13 more

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in musculoskeletal disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Laboratory-selected, probioticFrontiers in nutrition · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 15 countries.

Alberto MiglioreRheumatology Unit, San Pietro Fatebenefratelli Hospital, Via Cassia 600- 00189, Rome, Italy.ORCID https://orcid.org/0000-0002-3397-6478
Liudmila AlekseevaDepartment of Metabolic Diseases of Bone and Joints, VA Nasonova Research Institute of Rheumatology, Moscow, Russian Federation.
Sachin R AvasthiDepartment of Emergency Medicine, Dr Ram Manohar Lohia Hospital, Lucknow, India.
Raveendhara R BannuruCentre for Treatment Comparison and Integrative Analysis Division of Rheumatology, Tufts Medical Centre, Boston, MA, USA.
Xavier ChevalierUnit of Rheumatology, Henri Mondor Hospital, Créteil, France.
Thierry ConrozierService de Rhumatologie, Hôpital Nord Franche, Belfort, France.
Sergio CrimaldiChirurgia Ortopedica Mininvasiva e Nuove Tecnologie, Humanitas Research Hospital, Castellanza, Italy.
Gustavo C de CamposDepartment of Orthopaedics and Traumatology, University of Campinas, São Paulo, Brazil.
Demirhan DiracogluDepartment of Physical Medicine and Rehabilitation Division of Pain Medicine, Istanbul University, Istanbul, Turkey.
Gianfranco GigliucciRheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy.
Gabriel Herrero-BeaumontJoint and Bone Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.ORCID https://orcid.org/0000-0002-3241-991X
Giovanni IolasconDepartment of Medical and Surgical Specialties and Dentistry, University of Campania 'L Vanvitelli', Caserta, Italy.ORCID https://orcid.org/0000-0002-0976-925X
Ruxandra IonescuDepartment of Internal Medicine and Rheumatology Sf. Maria Hospital, University of Medicine and Pharmacy 'Carol Davila', Bucharest, Romania.
Jörg JeroschOrthopaedic Department, Johanna Etienne Hospital, Neuss, Germany.
Jorge LainsPhysical Rehabilitation Medicine Department, Rovisco Pais Medical and Rehabilitation Centre, Tocha, Portugal.
Emmanuel MaheuRheumatology Department, AP-HP, Saint-Antoine Hospital, Paris, France.
Souz MakriEUPATI Graduate and Patient Advocate, Brussels, Belgium.
Natalia MartusevichDepartment of Rheumatology, Belorussian State Medical University, Minsk, Belarus.
Marco Matucci-CerinicDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Karen PavelkaInstitute of Rheumatology, Prague, Czech Republic.
Robert J PetrellaDepartment of Family Medicine, School of Kinesiology University Western Ontario, Ontario, ON, Canada.
Raghu RamanAcademic Department of Orthopaedics, Hull and East Yorkshire NHS Trust Castle Hill Hospital, Cottingham, UK.
Umberto TarantinoDepartment of Orthopaedics and Traumatology, 'Policlinico Tor Vergata' Foundation, Rome, Italy.
Fatebenefratelli Hospital · ITAssociation of Rheumatologists of Russia · RUAtal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital · INBelarusian State Medical University · BYCarol Davila University of Medicine and Pharmacy · ROCastle Hill Hospital · GBCentro De Medicina Veterinária Anjos De Assis · PTHôpital Nord · FRHôpitaux Universitaires Henri-Mondor · FRHospital Universitario Fundación Jiménez Díaz · ESInstitute of Rheumatology · CZIstanbul University · TRJohanna-Etienne-Krankenhaus · DEPoliclinico Tor Vergata · ITSorbonne Université · FRTufts Medical Center · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Florence · ITWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early stage of osteoarthritis (OA) is characterized by joint stiffness and pain as well as by subclinical structural changes that may affect cartilage, synovium, and bone. At the moment, the lack of a validated definition of early osteoarthritis (EOA) does not allow to make an early diagnosis and adopt a therapeutic strategy to slow disease progression. Also, no questionnaires are available to evaluate the early stage, and therefore this remains an unmet need. Objective: Therefore, the purpose of the technical experts panel (TEP) of 'International Symposium of intra-articular treatment' (ISIAT) was to create a specific questionnaire to evaluate and monitor the follow-up and clinical progress of patients affected by early knee OA. Design: The items for the Early Osteoarthritis Questionnaire (EOAQ) were identified according to the following steps: items generation, items reduction, and pre-test submission. Methods: During the first step, literature has been reviewed and a comprehensive list of items about pain and function in knee EOA was drafted. Then, during the ISIAT (5th edition 2019), the draft has been discussed by the board, which reformulated, deleted, or subdivided some of the items. After the ISIAT symposium, the draft was submitted to 24 subjects affected by knee OA. A score based on the importance and the frequency was created and the items with a score ⩾0.75 were selected. After intermediate evaluation made by a sample of patients, the second and final version of the questionnaire EOAQ was submitted to the whole board for final analysis and acceptance in a second meeting (29 January 2021). Results: After an exhaustive elaboration, the final version of the questionnaire contains two domains (Clinical Features and Patients Reported Outcome) with respectively 2 and 9 questions, for a total of 11 questions. Questions mainly explored the fields of early symptoms and patients reported outcomes. Marginally, the need of the symptoms treatment and the use of painkillers were investigated. Conclusions: Adoption of diagnostic criteria of early OA is strongly encouraged and a specific questionnaire for the whole management of the clinical features and patients' outcome might really improve the evolution of OA in the early stages of the disease, when the treatment is expected to be more effective.

Indexed as

early osteoarthritisosteoarthritis monitoringquestionaire

Identifiers

PMID36860967
PMCPMC9969428
OpenAlexW4322096882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.